The iconic rise of Viagra has firmly established as a benchmark of pharmaceutical success, yet its legacy within the broader market now presents questions about future gains. Generic versions are eroding exclusivity , causing anxieties that betting on companies heavily reliant to Viagra's once-dominant influence could be a problematic decision , es